207 related articles for article (PubMed ID: 20615827)
21. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
[TBL] [Abstract][Full Text] [Related]
23. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
24. [Ductal carcinoma in situ (DCIS) and biopsy of the sentinel lymph node].
Chvalný P; Donát R; Dyttert D; Siska D; Sabol M; Králik R; Mracna P; Malina J; Veselý J; Duchaj B; Cích D; Lehotská V; Rauová K; Smreková M; Galbavý S; Macák D; Macháleková K; Bokes T
Rozhl Chir; 2011 Jun; 90(6):352-60. PubMed ID: 22026103
[TBL] [Abstract][Full Text] [Related]
25. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Hung WK; Ying M; Chan M; Mak KL; Chan LK
Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
[TBL] [Abstract][Full Text] [Related]
26. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
27. The use of sentinel lymph node biopsy in ductal carcinoma in situ.
Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W
Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339
[TBL] [Abstract][Full Text] [Related]
28. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
29. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
[TBL] [Abstract][Full Text] [Related]
30. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
32. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
[TBL] [Abstract][Full Text] [Related]
33. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
Pang J; Yan Z; Tan QT; Allen JC; Wang M; Lim GH
Clin Breast Cancer; 2024 Jun; 24(4):363-367. PubMed ID: 38458843
[TBL] [Abstract][Full Text] [Related]
35. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
36. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
[TBL] [Abstract][Full Text] [Related]
38. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
[TBL] [Abstract][Full Text] [Related]
39. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
Kósa C; Garami Z; Dinya T; Fülöp B
Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
[TBL] [Abstract][Full Text] [Related]
40. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]